SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

AARTI DRUGS

BSE: 524348 30 Sep 2025
Healthcare
₹ 486.6
Aarti Drugs Limited specializes in Pharmaceuticals within the Healthcare sector.

AARTI DRUGS - Share Price & Details

Market Cap
₹4,320
High /Low
575.0 / 312.0
Stock P/E
22.9
Book Value
₹149.0
Dividend Yield
0.21
ROCE
13.1
ROE
₹12.7
Face Value
10.0
PEG Ratio
-3.58
EVEBITDA
₹15.8
Debt
615
CMP / FCF
76.7
Debt to equity
₹0.45
NP Ann
168
High price all time
1,027
Piotroski score
₹4.0
Graham Number
262.0
No. Eq. Shares
9.19
Net CF
₹-2.17
Net profit
189
Price to book value
3.16
Interest Coverage
₹7.13
Low price all time
3.81
Industry PE
33.0
Reserves
₹1,278
Free Cash Flow
₹67.5

Broker Recommendations

No broker recommendations available

We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.


Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
AARTI DRUGS LTD.5213.4486.45209.65.334,32022.9
INDRAPRASTHA MEDICAL CORP.LTD.3719.6514.63650.65.61409624.4
RPG LIFE SCIENCES LTD.1741.5262.91689.20381336.8

Peer Comparison Chart


About AARTI DRUGS

Aarti Drugs Limited, with Security Code 524348, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

Should You Watch Aarti Drugs Limited for Sector Rotation Upside - Analyst Downgrades & Low Risk Capital Growth Plans

(28 Sep 2025)
Should You Watch Aarti Drugs Limited for Sector Rotation Upside ✌️【Growth Stocks】✌️ Maximize your capital growth with investment picks that...
Read more →

Why Hedge Funds Are Buying Aarti Drugs Limited in YEAR - Market Sentiment Surveys & Free Daily Stock Hotspot Analysis

(28 Sep 2025)
Why Hedge Funds Are Buying Aarti Drugs Limited in YEAR ✌️【Stock Observations】✌️ With precision timing and deep analysis, we help you ride...
Read more →

Aarti Drugs Hits Day Low at Rs 468.4 Amid Price Pressure

(26 Sep 2025)
Aarti Drugs, a small-cap pharmaceutical company, has seen its shares decline for the second consecutive day, with a notable drop today.
Read more →

Why We Think Aarti Drugs Limited's (NSE:AARTIDRUGS) CEO Compensation Is Not Excessive At All

(18 Sep 2025)
Key Insights Aarti Drugs to hold its Annual General Meeting on 24th of September CEO Prakash Patil's total compensation...
Read more →

Board of Aarti Drugs recommends Interim Dividend

(15 Sep 2025)
Aarti Drugs announced that the Board of Directors of the Company at its meeting held on 29 January 2025, has recommended a Interim dividend of Rs.1 pe...
Read more →

Aarti Drugs begins operations at Gujarat plant with 50% capacity, eyes ₹200 crore revenue

(15 Sep 2025)
Adhish Patil, CFO of Aarti Drugs, said the temporary closure of a process at the Tarapur unit after a minor HCL (formally known as hydrogen...
Read more →